In the current study, we demonstrated that overexpression of miR-223 in hepatocytes can also ameliorate CCl4-induced liver fibrosis by secreting TAZ-targeting IHH and by releasing miR-223-enriched EVs. The gene discussed is IHH; the disease is Hepatic fibrosis.